WFDC3 identified as a prognostic and immune biomarker in pancreatic cancer.

Biomol Biomed · 2025 · PMC12452133 · PMID 40350979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although N1-stage tumors showed a trend toward increased WFDC3 expression relative to N0-stage, this difference was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.